Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:48 PM
Ignite Modification Date:
2025-12-24 @ 3:48 PM
NCT ID:
NCT00040092
Eligibility Criteria:
* Patients with advanced (unresectable or metastatic) pancreatic adenocarcinoma (TNM stages II, III or IV)
* No previous systemic chemotherapy(unless given as a radiosensitizer).
* ECOG Performance Status 0-2
* Life expectancy equal to or greater than 12 weeks
* Adequate laboratory and organ functions
* Stabilizable pain (stable analgesic intake)
* No radiotherapy during 4 weeks prior to trial entry
* No evidence of ascites, pleural effusion or third space fluid accumulation
* Not currently using, and have not used in 4 weeks prior to entering trial, systemic steroids or hormonal therapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00040092
Study Brief:
Protocol Section:
NCT00040092